Advanced glycation end products (AGEs) augment production of vascular endothelial growth factor (VEGF) and tumor necrosis factor alpha (TNF alpha) in human monocyte-derived macrophages.
Main Authors: | Pertynska-Marczewska, M, Kiriakidis, S, Foxwell, B, Feldmann, M, Paleolog, E |
---|---|
Format: | Conference item |
Published: |
2003
|
Similar Items
-
Advanced glycation end products upregulate angiogenic and pro-inflammatory cytokine production in human monocyte/macrophages.
by: Pertyńska-Marczewska, M, et al.
Published: (2004) -
Advanced glycation end products (AGE) enhance vascular endothelial growth factor (VEGF) production in promonocytic leukaemia THP-1 cells
by: Pertńaska-Marczewska, M, et al.
Published: (2003) -
The effect of tumour necrosis factor-alpha (TNF-alpha) muteins on human neutrophils in vitro.
by: Tchorzewski, H, et al.
Published: (1993) -
Tumor necrosis factor-alpha (TNF) triggers a cytokine cascade yielding postoperative cognitive decline
by: Terrando, N, et al.
Published: (2010) -
Beneficial effects of tumour necrosis factor-alpha (TNF-alpha) blockade in rheumatoid arthritis (RA)
by: Maini, R, et al.
Published: (1995)